Researchers at the University of Liverpool have conducted a large-scale analysis that sheds light on the critical steps ...

A new study that has the potential to change the landscape of hepatitis B transmission in Africa. Researchers at the University of Liverpool and Liverpool School of Tropical Medicine conducted ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish ...

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo g ...

What’s the difference between influenza A and influenza B, and does it matter which you ... “You tend to have one or the other virus predominant at any given time,” said Anice Lowen, a ...

With several drugs in use that inhibit the hepatitis B virus polymerases (nucleos(t)ide analogues (or NUCs)), some argue that new direct-acting antiviral drugs, and new NUCs in particular ...

The company had been holding out hopes that the candidate could be another functional cure for the infection—meaning it reduces hepatitis B virus DNA and viral proteins to undetectable levels.

Hepatitis B is an infectious hepatocellular disease of global concern caused by hepatitis B virus (HBV), which belongs to Hepadnaviridae ... Figure 1. Genomic structure of DCH. Genomic structure of ...

2 Cluster of Excellence RESIST (EXC 2155), Hannover Medical School, Hannover, Germany Objective and design Human stem cell-derived hepatocyte-like cells (HLCs) have shown high potential as authentic ...